With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Following a big push to loosen up a little with potentially life-saving approvals, the FDA approved 59 new drugs in 2018—7 being biosimilars and 42 being approved in the US before any other country. | FDA 2019